This Thursday, March 18, the EMA informed Europe through a press conference that the AstraZeneca vaccine is “safe and effective”. At the same time, a link between the British Swedish vaccine and blood clots is established by Norwegian researchers.
The world of research and the medical profession is divided over AstraZeneca’s vaccine. According to a recent study by the head of the hematology department at Oslo University Hospital, the British Swedish vaccine may explain “The severe immune response” observed in some patients, responsible for the appearance of blood clots. According to Professor Pal André Holme, the injection of the serum causes a “Severe immune response” in certain patients where the production of antibodies would interfere with the action of blood platelets.
“I’m pretty sure it’s these antibodies that’s the cause, and I can’t think of any other reason than the vaccine triggering it.”
For the team of researchers at Oslo University Hospital, the vaccine is responsible for the formation of blood clots in three Norwegian patients. Asked by the Norwegian daily Verdens Gang, Prof. Pal André Holme affirms that “The three patients had no history of such a strong immune response. I’m pretty sure it’s those antibodies that are causing it, and I can’t think of any other reason than the vaccine triggering it. Interviewed on his level of certainty, Professor Holme spoke of“Clues” but indicates that it does not “Saw no other possibility today. Knowing that these are patients vaccinated between three and ten days before they develop serious complications. Earlier this week, the country’s health authorities announced the death of one of the three people hospitalized “They came in with severe pain, they had blood clots in unusual places, such as the stomach and brain. In addition, they had bleeding and a low platelet count “ explains Prof. Holme.
Vaccinations will resume today in France
The opinion of the European Medicines Agency (EMA) considers the vaccine ” safe and efficient “. This long-awaited decision allows countries like France to continue the vaccination campaign with the AstraZeneca vaccine. Jean Castex announced Thursday during his weekly press conference that the injections will resume this Friday. The vials could be stored “We have no concerns about storing the vaccine in refrigerators and we will therefore be able to resume appointments very quickly”, said Carine Wolf, president of the National Council of the Order of Pharmacists, at Parisian.
